Observational studyCancer medicine2023

Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities.

Tarun Mehra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.